WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) II L.P.

549300FCW61FNS1J4H70

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: exempted limited partnership (6XB7)
Jurisdiction: Cayman Islands
Entity created: March 4, 2021

Address

Country: Cayman Islands
Legal address: 89 Nexus Way, Camana BayKY1-9009 Grand CaymanCayman Islands
Head office: 280 Congress Street, 3rd Floor - Dock Square02210 BostonUnited States (US-MA)

Identifier

LEI: 549300FCW61FNS1J4H70
Registered: March 17, 2021 at 09:30 PM UTC
Last updated: December 1, 2025 at 06:01 PM UTC
Next renewal: December 17, 2026 at 02:19 PM UTC
Issuer: Ubisecure RapidLEI (529900T8BM49AURSDO55)
Registered with: Cayman Islands Monetary Authority (RA000087)
Identifier: 1939965
Verified against: Cayman Islands Monetary Authority (RA000087)
Verified as: 1939965
Corroboration: Partly confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/549300FCW61FNS1J4H70This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search